+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Imaging Modalities Market - Global Forecast 2026-2032- Product Image
Brain Imaging Modalities Market - Global Forecast 2026-2032- Product Image
New

Brain Imaging Modalities Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5925067
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain imaging modalities market is advancing at pace, shaped by new technologies, evolving clinical needs, and changing models of care delivery. For senior decision-makers navigating investment and strategy, understanding market drivers, adoption trends, and procurement factors is essential for sustainable growth and resiliency. The analysis below distills these complexities into targeted insights for executives across the global brain imaging landscape.

Market Snapshot: Brain Imaging Modalities Market

The Brain Imaging Modalities Market is projected to expand from USD 15.37 billion in 2025 to USD 16.90 billion in 2026, with future growth fueled by a CAGR of 10.55% and a forecast value of USD 31.04 billion by 2032. This expansion reflects heightened demand for faster, more precise imaging as clinical and research requirements intensify. Senior healthcare and industry leaders view the market as dynamic and opportunity-rich, underpinned by constant innovation and adoption of advanced technologies. Investment strategies increasingly focus on solutions that improve diagnostic speed, facilitate outpatient accessibility, and streamline clinical workflows across diverse care settings.

Scope & Segmentation

  • Modality Types: Computed Tomography (including Cone Beam and Conventional), Magnetic Resonance Imaging (covering Angiography, Diffusion, Functional, and Structural subtypes), Optical Imaging (such as Functional Near-Infrared Spectroscopy and Optical Coherence Tomography), Positron Emission Tomography (supporting Amyloid, Dopamine, and FDG Tracers), Single Photon Emission Computer Tomography (specializing in Dopamine Transporter), and Ultrasound Imaging (encompassing Biomicroscopy and Transcranial Doppler).
  • Applications: Diagnostics (for epilepsy, neurodegenerative conditions, traumatic brain injuries, tumors, and vascular diseases), Research (addressing brain mapping, neuroscience, and pharmaceutical development), and Therapeutic Monitoring (covering disease progression, surgical monitoring, and treatment responses).
  • End-Users: Academic institutions, ambulatory care facilities, diagnostic centers, home healthcare providers, hospitals, and research institutes in both government and private sectors, each with evolving needs for flexibility and data interoperability.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, with regional variation driven by infrastructure investment and differing clinical requirements.
  • Technologies: Detector sensitivity improvements, advanced pulse-sequence design, hybrid imaging architectures, artificial intelligence and analytics, multimodal integration, portable systems, and point-of-care capabilities are central to market differentiation and clinical adoption.

Key Takeaways: Strategic Insights for Decision-Makers

  • Hybrid imaging and analytics are transforming both clinical and research applications, enabling earlier detection and personalized monitoring while driving efficiency in workflows.
  • Growth in decentralized care and outpatient settings creates demand for portable, user-friendly systems that integrate effectively with existing IT and data management infrastructure.
  • Successful product adoption relies on adaptability to specific end-user workflows, as well as generation of robust real-world evidence to support differentiation across academic, hospital, and diagnostic center segments.
  • Manufacturers are shifting toward service-oriented business models, modular product upgrades, and enhanced interoperability to reduce integration risk and support long-term value creation for partners.
  • Geographic adoption remains highly influenced by reimbursement structures, local regulations, and healthcare infrastructure, necessitating tailored go-to-market and localization strategies for effective market penetration.

Tariff Impact: Navigating U.S. Policy Changes

Recent U.S. tariffs introduced in 2025 have heightened cost pressures for device manufacturers and procurement leaders. These policy shifts drive manufacturers to reconsider supplier location strategies and prioritize localization, directly affecting capital planning for healthcare providers. Institutions must also address new complexities in cross-border procurement, especially concerning the sourcing of sensitive components and tracers. Institutional buyers are responding by reassessing contracts, broadening supplier bases, and favoring modular system upgrades that facilitate adaptive risk management in volatile supply environments.

Methodology & Data Sources

This report is built on primary interviews with stakeholders in clinical, procurement, and research roles, complemented by thorough secondary research, encompassing literature review, regulatory documentation, and technical evaluation. Findings were validated through expert workshops to ensure accuracy and executive relevance.

Why This Report Matters

  • Empowers leadership to align procurement and investment initiatives with the latest modality innovations and evolving user requirements across regions and settings.
  • Enables effective risk mitigation strategies, critical for managing global supply chain disruption and the operational uncertainties arising from recent U.S. tariffs in the brain imaging modalities market.
  • Equips executive teams with actionable, granular market segmentation to guide technology adoption, commercial strategy, and regional implementation decisions.

Conclusion

Embracing technology integration, clinical evidence, and robust supply chain strategies will position organizations to capitalize on emerging opportunities. Adaptive models and collaboration across stakeholders are essential for meeting evolving clinical and operational demands in brain imaging.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Brain Imaging Modalities Market, by Modality
8.1. Computed Tomography
8.1.1. Cone Beam
8.1.2. Conventional
8.2. Magnetic Resonance Imaging
8.2.1. Angiography
8.2.2. Diffusion
8.2.3. Functional
8.2.4. Structural
8.3. Optical Imaging
8.3.1. Fnirs
8.3.2. Optical Coherence Tomography
8.4. Positron Emission Tomography
8.4.1. Amyloid
8.4.2. Dopamine
8.4.3. Fdg
8.5. Single Photon Emission Computer Tomography
8.6. Ultrasound Imaging
8.6.1. Biomicroscopy
8.6.2. Transcranial Doppler
9. Brain Imaging Modalities Market, by Patient Type
9.1. Adults
9.2. Pediatrics
9.3. Infants
10. Brain Imaging Modalities Market, by Application
10.1. Diagnostics
10.1.1. Epilepsy
10.1.2. Neurodegenerative Disorders
10.1.3. Traumatic Brain Injury
10.1.4. Tumor Detection
10.1.5. Vascular Disease
10.2. Research
10.2.1. Brain Mapping
10.2.2. Neuroscience
10.2.2.1. Basic Research
10.2.2.2. Clinical Research
10.2.3. Pharmaceutical Development
10.3. Therapeutic Monitoring
10.3.1. Disease Progression Tracking
10.3.2. Surgical Monitoring
10.3.3. Treatment Response Assessment
11. Brain Imaging Modalities Market, by End User
11.1. Academic Institutions
11.1.1. Medical Schools
11.1.2. Universities
11.2. Ambulatory Care Facilities
11.3. Diagnostic Centers
11.4. Home Healthcare
11.5. Hospitals
11.6. Research Institutes
11.6.1. Government Labs
11.6.2. Private Labs
12. Brain Imaging Modalities Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Brain Imaging Modalities Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Brain Imaging Modalities Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Brain Imaging Modalities Market
16. China Brain Imaging Modalities Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Advantis Medical Imaging
17.7. AiM Medical Robotics
17.8. Boston Scientific Corporation
17.9. Bruker Corporation
17.10. Canon Medical Systems Corporation
17.11. Elekta AB
17.12. EMVision Medical Devices Ltd.
17.13. Esaote SpA
17.14. Fujifilm Holdings Corporation
17.15. GE HealthCare Technologies, Inc.
17.16. Hitachi, Ltd.
17.17. Hologic, Inc.
17.18. Hyperfine Research, Inc.
17.19. Magnetic Insight, Inc.
17.20. Medtronic PLC
17.21. Octave Biosciences
17.22. Promaxo, Inc.
17.23. Royal Philips
17.24. Shimadzu Corporation
17.25. Siemens AG
17.26. Thermo Fisher Scientific Inc.
17.27. Toshiba Corporation
List of Figures
FIGURE 1. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRAIN IMAGING MODALITIES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRAIN IMAGING MODALITIES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BRAIN IMAGING MODALITIES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CONE BEAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CONE BEAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CONE BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIFFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIFFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIFFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FUNCTIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FUNCTIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FUNCTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY STRUCTURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY STRUCTURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY STRUCTURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FNIRS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FNIRS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FNIRS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY AMYLOID, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY AMYLOID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY AMYLOID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DOPAMINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DOPAMINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DOPAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FDG, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FDG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FDG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BIOMICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BIOMICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BIOMICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY INFANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY INFANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY INFANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TUMOR DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TUMOR DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TUMOR DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY VASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY VASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY VASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BRAIN MAPPING, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BRAIN MAPPING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BRAIN MAPPING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DISEASE PROGRESSION TRACKING, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DISEASE PROGRESSION TRACKING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DISEASE PROGRESSION TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY SURGICAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY SURGICAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY SURGICAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TREATMENT RESPONSE ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TREATMENT RESPONSE ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TREATMENT RESPONSE ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MEDICAL SCHOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MEDICAL SCHOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MEDICAL SCHOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY GOVERNMENT LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY GOVERNMENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PRIVATE LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PRIVATE LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 196. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 226. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 228. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 229. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 230. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 231. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 232. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 233. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 234. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 235. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 236. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 237. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 238. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 239. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 241. EUROPE BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 242. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 244. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 245. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 246. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 247. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 248. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 249. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 250. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 252. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 253. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 258. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 260. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 261. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 262. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 263. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 264. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 265. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 266. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 268. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 269. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 270. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 271. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 273. AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 274. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 276. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 277. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 278. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 279. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 280. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 281. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 282. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 283. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 284. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 285. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 286. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 287. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 289. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 290. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 291. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 292. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 293. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 294. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 295. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 296. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 297. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 298. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 299. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 301. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 302. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
TABLE 303. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY THERAPEUTIC MONITORING, 2018-2032 (USD MILLION)
TABLE 304. ASEAN BRAIN IMAGING MODALITIES MARKET SIZE, BY END U

Companies Mentioned

The key companies profiled in this Brain Imaging Modalities market report include:
  • Abbott Laboratories
  • Advantis Medical Imaging
  • AiM Medical Robotics
  • Boston Scientific Corporation
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Elekta AB
  • EMVision Medical Devices Ltd.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Hyperfine Research, Inc.
  • Magnetic Insight, Inc.
  • Medtronic PLC
  • Octave Biosciences
  • Promaxo, Inc.
  • Royal Philips
  • Shimadzu Corporation
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Toshiba Corporation

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.9 Billion
Forecasted Market Value ( USD ) by 2032 $ 31.04 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Brain Imaging Modalities Market Report 2025 - Product Image

Brain Imaging Modalities Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Functional Near-infrared Optical Brain Imaging Market - Global Forecast 2026-2032 - Product Image

Functional Near-infrared Optical Brain Imaging Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Brain Imaging Devices Market Size, Share & Trends Analysis Report by Product (Devices, Accessories), Application (Stroke, Brain Tumor), Modality (Fixed, Portable), End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Brain Imaging Devices Market Size, Share & Trends Analysis Report by Product (Devices, Accessories), Application (Stroke, Brain Tumor), Modality (Fixed, Portable), End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 220 Pages
  • Global
From
Brain Imaging Devices - Global Strategic Business Report - Product Image

Brain Imaging Devices - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Brain Imaging and Neuroimaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Brain Imaging and Neuroimaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From

About the Neuroimaging Market

The Magnetic Resonance Imaging (MRI) market is a subset of the larger Neuroimaging market, which is composed of technologies used to image the brain and nervous system. MRI is a non-invasive imaging technique that uses a powerful magnetic field and radio waves to create detailed images of the body's internal structures. MRI is used to diagnose and monitor a variety of neurological conditions, including stroke, brain tumors, and multiple sclerosis. MRI systems are composed of several components, including a magnet, a radio frequency (RF) coil, and a computer. The magnet creates a strong magnetic field, while the RF coil transmits and receives radio waves. The computer processes the signals and creates images of the body's internal structures. The MRI market is highly competitive, with a number of companies offering MRI systems. Some of the major players in the market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Medical Systems, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.